Shares of Gland Pharma rallied 8 per cent to Rs 4,087.65 on the BSE in intra-day trade on Thursday after the company reported strong revenue growth of 31 per cent year-on-year (YoY) at Rs 1,154 crore for the quarter ended June 2021 (Q1FY22). It had posted a revenue of Rs 884 crore in the year-ago quarter.
The stock was trading at its highest level since listing on November 20, 2020. In the past one month, it has outperformed Sensex by surging nearly 30 per cent as against a 0.44 per cent gain in the index.
Gland Pharma said the growth in revenue